Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteins

Mehdi Mesri(National Cancer Institute), Gary C. Starling(Sepragen Corporation (United States)), Ashwini Ghatpande(Sepragen Corporation (United States)), Richard A. Shimkets(Howard Hughes Medical Institute), Ferenc Boldog(Sepragen Corporation (United States)), Suresh Shenoy(Sepragen Corporation (United States)), Craig Hackett(Sepragen Corporation (United States)), Glennda Smithson(Takeda (United States)), Alison M. Bendele(Bolder Biotechnology, Inc.), Andrei I. Chapoval(Human Genome Sciences (United States)), Catherine E Burgess(Sepragen Corporation (United States)), Carol E. Peña(Sepragen Corporation (United States))
International Immunology
February 15, 2006
Cited by 21


Related Papers